In GnRH-ant co-treatment no effect on OHSS incidence was observed between OCP pre-treated cycles and non-pretreated cycles (2 RCTs; OR 0.98, 95% CI 0.28 to 3.40, n = 642; I2 = 0%) [47]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.